第一作者:
Frederick J,Raal
第一单位:
From the Faculty of Health Sciences, University of the Witwatersrand, Johannesburg (F.J.R.); the Cardiometabolics Unit, Zena and Michael A. Wiener Cardiovascular Institute, Marie-Josee and Henry R. Kravis Center for Cardiovascular Health, Icahn School of Medicine at Mount Sinai, New York (R.S.R.), and Regeneron Pharmaceuticals, Tarrytown (S.A., P.B, K.-C.C., D.A.G., N.K., R.P., D.M.W. G.D.Y., Y.Z.) - both in New York; the Department of Vascular Medicine, University of Amsterdam, Amsterdam (L.F.R., G.K.H., J.J.P.K.); the Department of Internal Medicine and Surgery, Federico II University, Naples, Italy (P.R.); and the Clinical Lipidology and Rare Lipid Disorders Unit, Department of Medicine, Université de Montréal Community Gene Medicine Center, Lipid Clinic Chicoutimi Hospital and ECOGENE-21 Clinical and Translational Research Center, Chicoutimi, QC, Canada (D.G.).
作者:
主题词
青少年(Adolescent);成年人(Adult);老年人(Aged);抗体, 单克隆(Antibodies, Monoclonal);抗胆固醇血症药(Anticholesteremic Agents);儿童(Child);胆固醇, LDL(Cholesterol, LDL);双盲法(Double-Blind Method);女(雌)性(Female);纯合子(Homozygote);人类(Humans);高胆固醇血症Ⅱ型(Hyperlipoproteinemia Type II);输注, 静脉内(Infusions, Intravenous);最小二乘法分析(Least-Squares Analysis);男(雄)性(Male);中年人(Middle Aged);突变(Mutation);受体, LDL(Receptors, LDL);青年人(Young Adult)
DOI
10.1056/NEJMoa2004215
PMID
32813947
发布时间
2021-12-04
- 浏览1
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文